Philips | PHIA - Equity Capital And Reserves


Philips reported EUR11.39B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
ABB USD 15.37B 720M Mar/2026
Abbott USD 52.06B 69M Mar/2026
Aena EUR 9.89B 387.7M Mar/2026
Alcon AG USD 22.13B 99M Mar/2026
ASM International NV EUR 4.29B 282.8M Mar/2026
ASML Holding 20.83B 1.22B Mar/2026
AstraZeneca USD 47.33B 1.33B Mar/2026
Bayer EUR 28.85B 2.9B Mar/2026
Boston Scientific USD 25.86B 1.63B Mar/2026
Demant DKK 9.84B 446M Dec/2025
EDAP TMS EUR 23.32M 4.5M Sep/2025
Edwards Lifesciences USD 10.33B 10.1M Mar/2026
Essilor EUR 38.89B 1.07B Dec/2025
Fresenius EUR 19.77B 1.14B Dec/2025
Fresenius Medical Care EUR 14.2B 13.95B Mar/2026
Geberit CHF 1.54B 237.4M Mar/2025
Getinge SEK 33.01B 2.75B Dec/2024
GN Store Nord DKK 10.12B 4.76B Mar/2026
GRIFOLS EUR 5.46B 171M Mar/2026
HeidelbergCement EUR 19.3B 2.08B Dec/2025
Intuitive Surgical USD 17.47B 349.5M Mar/2026
Koninklijke Philips EUR 11.42B 1.45B Mar/2026
Legrand EUR 7.74B 442.1M Mar/2026
Lonza CHF 9.13B 513M Dec/2025
Medtronic USD 48.99B 128M Dec/2025
Merck EUR 29.74B 1.15B Mar/2026
Philips EUR 11.39B 403M Mar/2026
Sanofi EUR 72.81B 1.1B Mar/2026
SAP EUR 44.86B 109M Mar/2026
Schneider Electric EUR 24.2B 2.75B Dec/2025
Smith & Nephew USD 5.54B 331M Dec/2025
Trinity Biotech USD -71.98M 17.26M Dec/2025